Skip to content

Psilocybin: all studies

Page 287 of 440: studies 2,861 to 2,870 of 4,400, newest first. Back to the psilocybin overview

Research

Increasing Use of “Ecstasy“ (MDMA) and other Hallucinogens on a College Campus

Journal of American College Health May 1, 1994 Michael J. Cuomo, Paul G. Dyment, Victoria M. Gammino 82 citations

We conducted a random survey of illicit drug use by undergraduate students at a private southern university in 1990 and compared the results with results from a similar 1986 survey of that college's student population. During the 4 years since the first study, the prevalence of cocaine use declined from 39% to 21%, and use of traditional amphetamines declined from 22% to 12%. No significant...

Dose-Response Study of N,N-Dimethyltryptamine in Humans

Archives of General Psychiatry February 1, 1994 Ruck J. Strassman 454 citations

BACKGROUND: Validation of animal models of hallucinogenic drugs' subjective effects requires human data. Previous human studies used varied groups of subjects and assessment methods. Rating scales for hallucinogen effects emphasized psychodynamic principles or the drugs' dysphoric properties. We describe the subjective effects of graded doses of N,N-dimethyltryptamine (DMT), an endogenous...

Adverse consequences of lysergic acid diethylamide

Addiction October 1, 1993 Henry David Abraham, Andrew M. Aldridge 140 citations

Abstract The continued endemic use of hallucinogenic drugs, and of LSD in particular, raises concern regarding their short and long term adverse consequences. The epidemiology of LSD abuse is reviewed suggesting an increase in LSD use among the young as the prevalence rates for other substances continues to fall. Evidence supports the association of LSD use with panic reactions, prolonged...

Adolescent drug use in Wales

British Journal of Addiction February 1, 1992 Christopher D Smith, Don Nutbeam 45 citations

Abstract As part of a larger survey of health‐related behaviours, 2239 15–16‐year‐olds in Wales provided information on their use of eight different types of drugs. Key findings indicate that just over a fifth of this age group report to having tried drugs at some time, while a tenth say they have done so within the past month. The most frequently reported substances were marijuana, solvents...

Religious use of hallucinogenic fungi: A comparison between Siberian and Mesoamerican cultures

Karstenia 1992 Harri Nyberg 28 citations

NYBERG, H.1992: Religious use of hallucinogenic fungi: A comparison between Siberian and Mesoamerican cultures.-Karstenia32:71-80.The religious uses of hallucinogenic mushrooms in northern Eurasian and Mesoamerican cultures are compared.In northern Eurasia, some shamanistic cultures have used the Fly Agaric (Amanita muscaria (L.) Pers.);Mesoamericans, mainly mushrooms of the genus Psilocybe...

DOI: 10.29203/ka.1992.294 (opens in new tab) Psilocybin Veneration Hallucinogen Amanita +1

Biotransformation of Tryptamine in Fruiting Mycelia ofPsilocybe cubensis

Planta Medica June 1, 1989 Jochen Gartz 13 citations

Mycelial cultures of PSILOCYBE CUBENSIS, with the ability to form psilocybin and psilocin DE-NOVO, also hydroxylated and methylated fed tryptamine to give psilocin in up to 3.3% dry mass of the obtained fruit bodies. By using HPLC and TLC, it was found that these mushrooms contain only a small amount of psilocybin (0.01-0.2% dry mass). The values of psilocin are the highest described in any...

DOI: 10.1055/s-2006-961995 (opens in new tab) Psilocybin Tryptamine Mycelium Biotransformation +3

Shamans, Sacraments, and Psychiatrists

Journal of Psychoactive Drugs 1989 Gary Bravo, Charles S. Grob 38 citations

This article reviews the role of psychedelic drugs as potential tools for psychiatric research and practice. The decline in the utilization of these substances is linked to social reactions, which led to psychedelics being scheduled as controlled substances and consequently unavailable for human research. Three different paradigms for the use of psychedelics in psychiatry are reviewed: the...

Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline

European Journal of Pharmacology 1989 James B. Appel, Patrick M. Callahan 34 citations

In order to further evaluate the extent to which particular 5-HT receptor subtypes (5-HT1, 5-HT2) might be involved in the behavioral effects of hallucinogenic drugs, rats were trained to discriminate mescaline (10 mg/kg i.p.) from saline and were given substitution (generalization) and combination (antagonism) tests with putatively selective serotonergic and related neuroactive compounds. The...

Effects of intraocular mescaline and LSD on visual-evoked responses in the rat

Pharmacology, Biochemistry, and Behavior 1989 Janis T. Eells, Douglas M. Wilkison 10 citations

The effects of mescaline and LSD on the flash-evoked cortical potential (FEP) were determined in unrestrained rats with chronically-implanted electrodes. Systemic administration of mescaline or LSD significantly attenuated the primary component of the FEP at three stimulus intensities with the greatest effect observed 60-90 minutes following drug administration. The magnitude and specificity of...